<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03314467</url>
  </required_header>
  <id_info>
    <org_study_id>BE76201733442</org_study_id>
    <nct_id>NCT03314467</nct_id>
  </id_info>
  <brief_title>Role of Obstructive Sleep Apnea Syndrome in the Occurrence of Diabetic Retinopathy in Type 2 Diabetes.</brief_title>
  <official_title>Role of Obstructive Sleep Apnea Syndrome in the Occurrence of Diabetic Retinopathy in Type 2 Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Saint Pierre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Saint Pierre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetic retinopathy (DR) is the most common visual complication of diabetes. Risk factors
      for developing DR are diabetes duration, glycemic control, and hypertension . The prevalence
      ranges from 17 to 61% according to the diabetes duration .

      Obstructive sleep apnea syndrome (OSAS) is very frequent in Type 2 Diabetes population,
      reaching a prevalence of 23-48% .

      Few is known about the exact role of OSAS in the development of DR. A recent study has shown
      that OSAS is an independent predictor for the progression to pre-/proliferative DR. The
      purpose of the present study is to assess if the presence of OSA in diabetic patients is a
      predictive factor for DR occurrence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetic retinopathy (DR) is the most common visual complication of diabetes. Risk factors
      for developing DR are diabetes duration, glycemic control, and hypertension. The prevalence
      ranges from 17 to 61% according to the diabetes duration.

      Obstructive sleep apnea syndrome (OSAS) is very frequent in Type 2 Diabetes population,
      reaching a prevalence of 23-48%.

      Few is known about the exact role of OSAS in the development of DR. A recent study has shown
      that OSAS is an independent predictor for the progression to pre-/proliferative DR. The
      purpose of the present study is to assess if the presence of OSA in diabetic patients is a
      predictive factor for DR occurrence.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 6, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of obstructive sleep apnea in diabetic patients is a predictive factor for diabetic retinopathy occurence</measure>
    <time_frame>1 month</time_frame>
    <description>obstructive sleep apnea is defined as apnea-hypopnea index &gt; 15 on polysomnography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between severity of obstructive sleep apnea and presence of diabetic retinopathy</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Cases DR</arm_group_label>
    <description>diabetic patients with diabetic retinopathy (DR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cases other</arm_group_label>
    <description>diabetic patiens with other/multiple ocular disorder(s)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>diabetic patients without ocular abnormalities</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>polysomnography</intervention_name>
    <description>classical polysomnography
non invasive measurement of blood pressure
blood test: determination of HbA1c, glucose, C-peptide, hemoglobin, white blood cell count, trombocytes</description>
    <arm_group_label>Cases DR</arm_group_label>
    <arm_group_label>Cases other</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>arterial tension</other_name>
    <other_name>blood test</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      bloodserum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with a diagnosis of diabetes type I or type II who went to a ocular screening
        visit to assess ocular complications associated with diabetes are asked to undergo an
        in-lab polysomnography..
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of diabetic type II

          -  able to undergo an in-lab polysomnography

        Exclusion Criteria:

          -  known presence of obstructive sleep apnea and treated by CPAP
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie Bruyneel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre hospitalier universitaire St Pièrre - Pneumologie/Labo du sommeil</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marie Bruyneel, MD, PhD</last_name>
    <phone>+3225354203</phone>
    <email>marie_bruyneel@stpierre-bru.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pham Anh Hong Nguyen, MD</last_name>
    <email>pham_nguyen@stpierre-bru.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Saint Pièrre</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Bruyneel, MD, PhD</last_name>
      <email>marie_bruyneel@stpierre-bru.be</email>
    </contact>
    <contact_backup>
      <last_name>Pham Anh Hong Nguyen, MD</last_name>
      <email>pham_nguyen@stpierre-bru.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Altaf QA, Dodson P, Ali A, Raymond NT, Wharton H, Fellows H, Hampshire-Bancroft R, Shah M, Shepherd E, Miah J, Barnett AH, Tahrani AA. Obstructive Sleep Apnea and Retinopathy in Patients with Type 2 Diabetes. A Longitudinal Study. Am J Respir Crit Care Med. 2017 Oct 1;196(7):892-900. doi: 10.1164/rccm.201701-0175OC.</citation>
    <PMID>28594570</PMID>
  </reference>
  <reference>
    <citation>Mok Y, Tan CW, Wong HS, How CH, Tan KL, Hsu PP. Obstructive sleep apnoea and Type 2 diabetes mellitus: are they connected? Singapore Med J. 2017 Apr;58(4):179-183. doi: 10.11622/smedj.2017027.</citation>
    <PMID>28429032</PMID>
  </reference>
  <reference>
    <citation>Vujosevic S, Midena E. Diabetic Retinopathy in Italy: Epidemiology Data and Telemedicine Screening Programs. J Diabetes Res. 2016;2016:3627465. Epub 2016 Nov 21. Review.</citation>
    <PMID>27990441</PMID>
  </reference>
  <reference>
    <citation>Zhou Y, Zhang Y, Shi K, Wang C. Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review. Medicine (Baltimore). 2017 Jun;96(22):e6754. doi: 10.1097/MD.0000000000006754. Review.</citation>
    <PMID>28562529</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2017</study_first_submitted>
  <study_first_submitted_qc>October 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2017</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Saint Pierre</investigator_affiliation>
    <investigator_full_name>Marie Bruyneel</investigator_full_name>
    <investigator_title>Chef de clinique</investigator_title>
  </responsible_party>
  <keyword>diabetic retinopathy</keyword>
  <keyword>diabetes</keyword>
  <keyword>arterial hypertension</keyword>
  <keyword>obstructive sleep apnea syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

